aurintricarboxylic acid has been researched along with fluorescein-5-isothiocyanate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, Y; Chen, CW; Lin, WW; Tsi, CJ | 1 |
1 other study(ies) available for aurintricarboxylic acid and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inh
Topics: Animals; Apoptosis; Aurintricarboxylic Acid; Binding Sites; Cells, Cultured; Drug Interactions; Fluorescein-5-isothiocyanate; I-kappa B Kinase; I-kappa B Proteins; Lipopolysaccharides; Macrophages; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Protective Agents; Protein Serine-Threonine Kinases; Rats; Transcription Factor AP-1; Transcription, Genetic | 2002 |